A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Bristol-Myers Squibb
Novartis
Novartis
Novartis
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
INSYS Therapeutics Inc
Novartis